logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11 Age at first use and primary drug. EU, Croatia, Norway and Turkey, 2011 or most recent year available

Part (iii) Age at first use distribution, All outpatient clients(%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge knownAge not known
Opiates8.039.927.212.56.63.11.61.122.214763221973
Cocaine7.443.125.511.36.33.21.81.322.1505526154
Stimulants15.454.517.86.23.31.60.80.419.5124483897
Hypnotics and sedatives13.626.016.212.09.97.55.49.526.753931928
Hallucinogens14.856.718.84.41.92.20.50.619.3788148
Volatile substances57.330.16.31.43.30.80.30.516.6632141
Cannabis 46.243.96.91.50.80.30.20.216.57929617515
Other substances 23.335.616.27.87.63.03.13.521.922951176
Total18.741.920.89.04.92.41.31.020.629903652932
 

Notes:

The number of treatment clients in each country is listed in Table TDI-7.

See also Table TDI-107 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012 — Table TDI — outpatient treatment centres.

Page last updated: Friday, 26 April 2013